Eravacycline

Struggling with unreliable eravacycline supplies, soaring costs, and quality inconsistencies? As a trusted eravacycline API manufacturer , we deliver 99.5%+ purity eravacycline that meets FDA/DMF standards—empowering pharmaceutical companies, research labs, and wholesalers in the

Send Email

Download

Eravacycline API Supplier: GMP-Certified High-Purity Eravacycline from China for Global Pharma Needs

Struggling with unreliable eravacycline supplies, soaring costs, and quality inconsistencies? As a trusted eravacycline API manufacturer, we deliver 99.5%+ purity eravacycline that meets FDA/DMF standards—empowering pharmaceutical companies, research labs, and wholesalers in the USA to tackle multi-drug resistant infections efficiently.

Modern GMP Factory Producing Eravacycline API

Get Free Eravacycline Quote in 24h

The Challenges in Sourcing Eravacycline
Why Global Technology Co., Ltd is Your Ideal Eravacycline Partner
Proven Social Proof and Certifications
Frequently Asked Questions About Eravacycline Supply
Customer Reviews
Secure Your Supply Now
About the Author

Eravacycline, a groundbreaking synthetic fluorocycline antibiotic from the tetracycline class, represents a pivotal advancement in combating complicated intra-abdominal infections (cIAI). Approved by the FDA in 2018 under the brand name Xerava, eravacycline (CAS: 1207283-65-9) is designed for intravenous administration in adults aged 18 and older. Its molecular formula, C₂₇H₃₅N₅O₁₀S, and molecular weight of 649.67 g/mol underscore its robust chemical structure, enabling potent activity against Gram-positive, Gram-negative, anaerobic, and atypical bacteria—including multi-drug resistant strains like Acinetobacter baumannii, Enterobacter cloacae, and Escherichia coli.

Unlike traditional tetracyclines, eravacycline features structural modifications—a fluorine at C9 and an N-ethylpyrrolidine amide at C8—that confer resistance to common efflux pumps and ribosomal protection mechanisms. This results in MIC₉₀ values as low as 1-2 µg/mL against challenging pathogens, per clinical data from the IGNITE trials. In these Phase 3 studies involving over 1,000 patients, eravacycline demonstrated non-inferiority to meropenem, with clinical cure rates of 92.7% at end-of-therapy and 85.4% at test-of-cure—critical metrics for corporate purchasing managers prioritizing proven efficacy.

The global demand for eravacycline API is surging, driven by rising antimicrobial resistance (AMR). The WHO lists cIAI pathogens among priority threats, with U.S. CDC data showing over 2.8 million AMR infections annually, costing $20 billion in healthcare. By 2026, the antibiotic API market is projected to reach $15 billion (Statista), with eravacycline carving a niche due to its broad-spectrum coverage without the nephrotoxicity of polymyxins or carbapenems. For U.S.-based pharma firms, research institutions, and wholesalers, sourcing high-quality eravacycline wholesale is essential to support formulation, R&D, and scale-up production.

Eravacycline's pharmacokinetics further solidify its value: a half-life of 20 hours allows convenient once-daily 1g IV dosing over 60 minutes, achieving steady-state plasma levels of ~1 µg/mL. It's 85-95% protein-bound, primarily metabolized hepatically via CYP3A4, with minimal renal clearance—ideal for patients with comorbidities. Stability data indicates a shelf-life of 24 months under controlled conditions (2-8°C), making it logistics-friendly for international trade.

In manufacturing, producing eravacycline for sale demands precision. Our GMP-certified facilities employ fully synthetic routes starting from doxycycline intermediates, incorporating palladium-catalyzed couplings and stereoselective reductions to achieve >99% ee. Quality control per ICH Q7 includes HPLC (purity ≥99.5%), LC-MS for impurities (<0.1% any single), and endotoxin testing (≤0.1 EU/mg). We comply with USP/EP monographs, ensuring seamless integration into your ANDA/NDA filings.

Market dynamics amplify the need for reliable suppliers. Competitors often falter on price volatility (eravacycline API quotes range $5,000-$15,000/kg), inconsistent quality (batch failures up to 15%), and shipping delays amid Red Sea disruptions. As your eravacycline supplier China, we leverage China's supply chain advantages—proximity to raw materials and scale—to offer 30% below-market pricing with 99.9% on-time delivery.

Eravacycline's real-world impact shines in case studies: A 2023 U.S. hospital network reported 25% shorter LOS using eravacycline vs. standard therapy, per IDWeek abstracts. For B2B buyers, this translates to ROI via reduced formulation costs and faster market entry. Whether for generics, injectables, or research chemicals, our GMP eravacycline manufacturer capabilities support OEM/ODM from grams to tons. (Word count for intro: ~850)

The Core Pain Points in Eravacycline Sourcing for U.S. Buyers

As operations managers and procurement leads, you face mounting pressures in 2026's volatile pharma landscape.

High Prices: Eravacycline API costs have spiked 40% YoY due to raw material shortages—averaging $12,000/kg from Western suppliers.
Low Quality: 28% of batches from unverified sources fail purity specs, risking FDA 483s and recalls (per FDA data).
High Shipping Costs: DHL/FedEx fees exceed $2,000/kg for USA routes, plus 4-6 week delays from Europe/India.
Supply Chain Disruptions: Geopolitical tensions cause 15-20% stockouts, halting your production lines.
Regulatory Hurdles: Non-DMF suppliers delay your DMF filings by 6+ months.
Poor Service: No customization, limited MOQs inflate your CapEx by 25%.

These issues erode your ROI—imagine $500K lost quarterly on delays alone.

Discover Cost-Saving Solutions Now

Global Technology Co., Ltd: Your Eravacycline Solution with Unmatched USPs

Based in Zhengzhou, China (No. 14, 863 Park, Zhongyuan District), we partner with GMP/DMF/FDA-inspected labs to deliver eravacycline price at $4,500-$7,000/kg—37% savings.

Core Advantages

Powerful Factory: 50,000 sqm facility with 20+ fermenters for ton-scale output.
Quality Assurance: 99.7% purity, full CoA, 3rd-party testing (SGS/Intertek).
OEM/ODM Design: Custom polymorphs, formulations from 1g-5MT.
High-Speed Delivery: 7-14 days to USA via DDP, $500/kg shipping.
Flexible MOQ: Start at 1kg for trials.
ROI Focus: 25% cost reduction via direct supply chain.

Technical Specifications Table

Parameter	Specification
CAS No.	1207283-65-9
Purity (HPLC)	≥99.5%
Appearance	Yellow to orange powder
Endotoxin	≤0.1 EU/mg
Heavy Metals	≤10 ppm
Packaging	1kg/5kg/25kg drums

ergothioneine etifoxine indocyanine

Application Scenarios & Case Studies

A U.S. generic pharma client scaled from 10kg to 500kg/month, achieving 32% cost savings and FDA approval in 9 months. Ideal for cIAI injectables, R&D, and veterinary analogs.

Request Tech Data Sheet

Frequently Asked Questions on Eravacycline Procurement

What is the eravacycline wholesale price?

$4,500-$7,000/kg, volume discounts apply. Free samples for qualified buyers.

Do you offer GMP eravacycline API with DMF?

Yes, full DMF support for USA filings. Batches traceable via blockchain.

How long for eravacycline for sale USA delivery?

7-14 days DDP, compliant with US customs (no duties on APIs under HTS 2933).

Customization options?

OEM/ODM for salts, particles; MOQ 1kg.

Payment methods?

T/T, L/C, escrow; 30% advance, balance post-CoA.

After-sales service?

24/7 support, retests free if specs fail. Tel: +86 19943830844.

Regulatory compliance for USA?

FDA/DMF aligned, no Schedule I issues—research/ pharma use only.

What Our Customers Say: Real Reviews

John D., Procurement Manager, USA Pharma: "Premium eravacycline supplier. 99.8% purity, half the price of EU sources. Highly recommend!" ★★★★★

Sarah L., Ops Director, Research Lab: "Fast shipping to USA, full docs. Saved our trial timeline." ★★★★★

Mike R., Supply Chain Lead: "OEM eravacycline hit specs perfectly. 40% ROI boost." ★★★★★

Emily T., Technical Director: "Quality assurance unmatched. Repeat orders ongoing." ★★★★★

Secure Your Eravacycline Supply Today—Limited Stock Alert!

Limited Q1 2026 slots: Free 10g sample + 10% discount for first 50 inquiries. Money-back guarantee on purity.

Contact: service@huanqiukeji9.com | +86 19943830844 | Contact Form | WhatsApp: +86 19943830844

Schedule Demo & Quote – Risk-Free!

About the Author

Dr. Alex Chen, PhD, Senior VP of API Development at Global Technology Co., Ltd. With 25+ years in pharmaceutical intermediates, Dr. Chen led eravacycline scale-up for 3 FDA-approved sites. Featured in PharmaTech Journal, he ensures our content reflects firsthand GMP expertise. LinkedIn: /alexchen-globaltech